alexa A Case Report On A 29 Year Old Male With Difficulty To Treat Bronchial Asthma In Exacerbation: Rediscovering Asthma COPD Overlap Syndrome (ACOS)
ISSN: 2161-105X

Journal of Pulmonary & Respiratory Medicine
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

4th International Conference on Chronic Obstructive Pulmonary Disease
May 29-31, 2017 Osaka, Japan

Christoper John N Tibayan and Jonathan Arquiza
Ospital ng Makati, Philippines
Posters & Accepted Abstracts: J Pulm Respir Med
DOI: 10.4172/2161-105X-C1-025
Abstract
Background: Asthma COPD Overlap Syndrome (ACOS) was formally described by the Joint Project of GINA and GOLD as persistent airflow limitation with several features usually associated with both Asthma and COPD. ACOS is identified by the features shared with both Asthma and COPD. The underlying cause though remains unknown; hence the project did not offer current formal definition. Objective: The objective of this article is to present a case of 29 years old male initially diagnosed of Asthma and on further diagnostic investigation is a likely case of Asthma COPD Overlap Syndrome (ACOS). Overview of the Case: XY is a 29 years old male, asthmatic and 8 pack years’ smoker who presented with chronic obstructive respiratory symptoms with non-significant improvement on control of exacerbation despite standard maximal therapy. Diagnostic tests such as Pulmonary Function Tests, 2D Echo, Chest CT Scan and assay for alpha 1 anti-trypsin were done to rule out for other disease entities and prognosticate the patient’s condition leading to the diagnosis of Asthma COPD Overlap Syndrome (ACOS). Conclusion: Asthma COPD Overlap Syndrome (ACOS) as a disease entity is still under debate and still has no current formal definition due to lack of specific biomarkers and lack of defining characteristics. Despite this, management should not be compromised, since these patients often present with higher rates of exacerbations, hospitalization, associated co-morbid illness and mortality. Treatment can be maximized to the so called Triple Therapy defined as combination Long Acting Beta Agonist + Inhaled Corticosteriod + Long Acting Muscarinic Antagonist, however management strategies must be always individualized depending on co morbid illness, patient’s functional capacity and response to initial treatment.
Biography

Email: [email protected]

image PDF   |   image HTML
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords